Ryman completes Retail Bookbuild, raising $902 million
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
10 March 2023
Ryman completes Retail Bookbuild, raising $902 million
Ryman is pleased to announce the successful completion of the shortfall bookbuild of
its Retail Entitlement Offer (Retail Bookbuild). The completion of the Retail
Bookbuild concludes the final stage of Ryman’s underwritten 1 for 2.81 accelerated
pro rata entitlement offer of new ordinary shares (the Offer) under which Ryman has
raised $902 million.
Summary of the Retail Bookbuild
Approximately 25 million New Shares, representing entitlements not taken up by
eligible retail shareholders and entitlements of ineligible retail shareholders in the
Retail Entitlement Offer, were offered for sale in the Retail Bookbuild.
The Retail Bookbuild was well supported, clearing at a price of $5.25 per New Share
(Bookbuild Price), which represents a premium of $0.25 (Premium) above the
offer price of $5.00 per New Share.
Additional Shares applied for by eligible retail shareholders in the Retail Entitlement
Offer will be allocated in full to those shareholders at the Bookbuild Price. Scaling has
been applied to institutional and broker bids in accordance with the terms set out in
the Offer Document dated 15 February 2023.
CEO Richard Umbers said, “We are very pleased with the level of support received
across both the retail and institutional components of our equity raising and to be able
to return a premium to shareholders who did not or could not participate. Proceeds
from the equity raising enable Ryman to be well positioned to execute its growth
framework and maintain the high standard of care it is known for”
Payment of Premium
Eligible retail shareholders who elected not to take up their entitlements and ineligible
retail shareholders will receive the Premium (less any applicable withholding tax) for
each New Share sold in the Retail Bookbuild.
The Retail Premium is expected to be paid to those retail shareholders on or about
Tuesday, 14 March 2023.
Allotment of New Shares
The settlement date for New Shares to be issued under the Retail Entitlement Offer
and the Retail Bookbuild is Tuesday, 14 March 2023. Those New Shares are also
expected to be allotted and issued to commence trading on Tuesday, 14 March 2023.
All New Shares issued under the Retail Entitlement Offer and the Retail Bookbuild will
rank equally with Ryman’s existing ordinary shares.
Repayment of tranche 1 of the USPP Notes
As disclosed in the investor presentation dated 15 February 2023, Ryman will repay
the USPP Notes and associated costs in full using proceeds from the equity raise. The
first tranche of USPP Notes and associated costs will be repaid today, with the
remaining USPP Notes and associated costs expected to be repaid on or around
Friday, 24 March 2023.
About Ryman:
Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 45
retirement villages in New Zealand and Australia. Ryman villages are home to
approximately 13,700 residents, and the company employs approximately 6,800 staff.
Contacts:
Investor queries:
Hayden Strickett, Head of Investor Relations,
+64 27 303 1132 or hayden.strickett@rymanhealthcare.com
Media queries: Marsha Cadman, Chief Sales and Marketing Officer
+61 414 790 480 or marsha.cadman@rymanhealthcare.com
Important Notice
This communication is not for distribution or release in the United States. This communication
does not constitute an offer to sell, or the solicitation of an offer to buy, any securities in the
United States. The entitlements and the New Shares have not been, and will not be, registered
under the U.S. Securities Act of 1933, as amended (U.S. Securities Act), or the securities laws
of any state or other jurisdiction of the United States, and may not be offered or sold, directly
or indirectly, in the United States or to any person acting for the account or benefit of any
person in the United States (to the extent such person is acting for the account or benefit of a
person in the United States).
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.